Medpace Holdings, Inc. MEDP
Set alert
As of Nov 3, 10:13 AM ET
- YTD
- +17.84%
- 1 year
- +11.42%
- Open
- 648.80
- Prev close
- 648.14
- Mkt cap
- 18.54B
- Vol
- 18.06K
- Avg vol
- 257.43K
- EPS
- 18.01
- P/E
- 36.81
- Div yield
- 0.00%
More statistics
- Low
- 648.26
- High
- 664.10
- Forward P/E
- 32.64
- Beta
- 1.11
- Short ratio
- 6.09
- Inst. own
- 90.29%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 8, 2027
- 50-d avg
- 619.12
- 200-d avg
- 529.37
- 1y target
- 651.31
5D chart
Signals (115)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Nov 3, 9:30 AM | 44 minutes ago |
| SMA: Bullish | Nov 3, 9:30 AM | 44 minutes ago |
| MACD: Buy Signal | Nov 3, 9:30 AM | 44 minutes ago |
| RSI: Overbought | Nov 3, 9:30 AM | 44 minutes ago |
| SMA: Bearish | Nov 2, 3:10 PM | 19 hours ago |
| SMA: Bearish | Nov 2, 3:05 PM | 19 hours ago |
| SMA: Bullish | Nov 2, 3:00 PM | 19 hours ago |
| SMA: Bearish | Nov 2, 2:55 PM | 19 hours ago |
| SMA: Bullish | Nov 2, 2:50 PM | 19 hours ago |
| SMA: Bearish | Nov 2, 2:40 PM | 19 hours ago |
| MACD: Sell Signal | Nov 2, 2:40 PM | 19 hours ago |
| SMA: Bullish | Nov 2, 2:35 PM | 19 hours ago |
| SMA: Bearish | Nov 2, 2:30 PM | 19 hours ago |
| SMA: Bullish | Nov 2, 2:10 PM | 20 hours ago |
| MACD: Buy Signal | Nov 2, 2:10 PM | 20 hours ago |
| SMA: Bearish | Nov 2, 2:05 PM | 20 hours ago |
| SMA: Bullish | Nov 2, 2:00 PM | 20 hours ago |
| SMA: Bearish | Nov 2, 1:55 PM | 20 hours ago |
| SMA: Bullish | Nov 2, 1:50 PM | 20 hours ago |
| SMA: Bullish | Nov 2, 1:50 PM | 20 hours ago |
Newest 20 of 115.
News
21 hours ago zacks.com
CON vs. MEDP: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical Services sector have probably already heard of Concentra Group (CON) and Medpace (MEDP). But which of these two stocks presents investors with the…
3 days ago zacks.com
Medpace (MEDP) is a Great Momentum Stock: Should You Buy?
Does Medpace (MEDP) have what it takes to be a top stock pick for momentum investors? Let's find out.
5 days ago zacks.com
Medpace Holdings, Inc. (MEDP) Hits Fresh High: Is There Still Room to Run?
Medpace (MEDP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
-
1 week ago benzinga.com
BMO Capital Maintains Market Perform on Medpace Holdings, Raises Price Target to $670
BMO Capital analyst Sean Dodge maintains Medpace Holdings (NASDAQ:MEDP) with a Market Perform and raises the price target from $600 to $670.
-
1 week ago benzinga.com
UBS Maintains Neutral on Medpace Holdings, Raises Price Target to $700
UBS analyst Kevin Caliendo maintains Medpace Holdings (NASDAQ:MEDP) with a Neutral and raises the price target from $673 to $700.
-
1 week ago benzinga.com
Truist Securities Maintains Hold on Medpace Holdings, Raises Price Target to $633
Truist Securities analyst Jailendra Singh maintains Medpace Holdings (NASDAQ:MEDP) with a Hold and raises the price target from $609 to $633.
-
1 week ago benzinga.com
Barclays Maintains Equal-Weight on Medpace Holdings, Raises Price Target to $675
Barclays analyst Luke Sergott maintains Medpace Holdings (NASDAQ:MEDP) with a Equal-Weight and raises the price target from $625 to $675.
-
1 week ago benzinga.com
TD Cowen Maintains Hold on Medpace Holdings, Raises Price Target to $673
TD Cowen analyst Charles Rhyee maintains Medpace Holdings (NASDAQ:MEDP) with a Hold and raises the price target from $492 to $673.
1 week ago benzinga.com
Medpace Hldgs Q3 2026 Earnings Call Transcript
Medpace Hldgs (NASDAQ:MEDP) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
-
1 week ago benzinga.com
Medpace Holdings Raises FY2026 GAAP EPS Guidance from $17.25-$17.95 to $17.97-$18.32 vs $17.60 Est; Narrows FY2026 Sales Guidance from $2.805B-$2.885B to $2.835B-$2.855B vs $2.851B Est
Medpace Holdings (NASDAQ:MEDP) raises FY2026 GAAP EPS guidance from $17.25-$17.95 to $17.97-$18.32 vs $17.60 analyst estimate. Narrows FY2026 sales outlook from $2.805 billion-$2.885 billion to…
-
1 week ago benzinga.com
Medpace Hldgs Q3 EPS $4.84 Beats $4.44 Estimate, Sales $716.000M Beat $715.975M Estimate
Medpace Hldgs (NASDAQ:MEDP) reported quarterly earnings of $4.84 per share which beat the analyst consensus estimate of $4.44 by 9.01 percent. This is a 25.39 percent increase over earnings of $3.86…
1 week ago benzinga.com
SpaceX Jumps 10%, Nasdaq 100 Rises as AI Trade Returns: Stock Market Today
SpaceX's blowout third quarter and Super Micro's guidance hike revive the AI trade, lifting the Nasdaq 100 as Netflix and AT&T slide on results.
1 week ago benzinga.com
Meta, Tesla On Deck Wednesday As AI Spending, Auto Demand Face Test
Meta Platforms and Tesla headline Wednesday’s reports, with investors focused on whether AI investment can keep driving growth while Tesla’s core auto business weakens. Philip Morris International,…
2 weeks ago benzinga.com
Earnings Volatility Watch: Bloom Energy and Other 11 Stocks Are Priced For Double-Digit Swings
Options price moves above 10% in 12 stocks next week, from TTM Technologies at 20.73% to Stifel Financial at 10.03%. The reports land after a chip and memory selloff that also hit CoreWeave
-
3 weeks ago benzinga.com
Mizuho Maintains Outperform on Medpace Holdings, Raises Price Target to $700
Mizuho analyst Ann Hynes maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $665 to $700.
-
3 weeks ago benzinga.com
Barclays Maintains Equal-Weight on Medpace Holdings, Raises Price Target to $625
Barclays analyst Luke Sergott maintains Medpace Holdings (NASDAQ:MEDP) with a Equal-Weight and raises the price target from $600 to $625.
3 weeks ago benzinga.com
Here’s How Much You Would Have Made Owning Medpace Holdings Stock In The Last 10 Years
Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 10 years by 21.36% on an annualized basis producing an average annual return of 35.2%. Currently, Medpace Holdings has a…
-
1 month ago benzinga.com
Here's How Much $100 Invested In Medpace Holdings 10 Years Ago Would Be Worth Today
Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 10 years by 21.9% on an annualized basis producing an average annual return of 35.51%. Currently, Medpace Holdings has a…
-
1 month ago benzinga.com
UBS Upgrades Medpace Holdings to Neutral, Raises Price Target to $673
UBS analyst Kevin Caliendo upgrades Medpace Holdings (NASDAQ:MEDP) from Sell to Neutral and raises the price target from $405 to $673.
-
1 month ago benzinga.com
Here’s How Much You Would Have Made Owning Medpace Holdings Stock In The Last 5 Years
Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 5 years by 15.31% on an annualized basis producing an average annual return of 26.82%. Currently, Medpace Holdings has a…
2 months ago benzinga.com
If You Invested $1000 In Medpace Holdings Stock 10 Years Ago, You Would Have This Much Today
Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 10 years by 22.9% on an annualized basis producing an average annual return of 36.28%. Currently, Medpace Holdings has a…
2 months ago benzinga.com
If You Invested $100 In Medpace Holdings Stock 5 Years Ago, You Would Have This Much Today
Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 5 years by 14.56% on an annualized basis producing an average annual return of 26.38%. Currently, Medpace Holdings has a…
-
3 months ago benzinga.com
Mizuho Maintains Outperform on Medpace Holdings, Raises Price Target to $665
Mizuho analyst Ann Hynes maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $586 to $665.
-
3 months ago benzinga.com
BMO Capital Maintains Market Perform on Medpace Holdings, Raises Price Target to $600
BMO Capital analyst Sean Dodge maintains Medpace Holdings (NASDAQ:MEDP) with a Market Perform and raises the price target from $400 to $600.
-
3 months ago benzinga.com
Truist Securities Maintains Hold on Medpace Holdings, Raises Price Target to $609
Truist Securities analyst Jailendra Singh maintains Medpace Holdings (NASDAQ:MEDP) with a Hold and raises the price target from $462 to $609.
-
3 months ago benzinga.com
RBC Capital Maintains Outperform on Medpace Holdings, Raises Price Target to $692
RBC Capital analyst Ryan Halsted maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $484 to $692.
-
3 months ago benzinga.com
Baird Maintains Neutral on Medpace Holdings, Raises Price Target to $624
Baird analyst Eric Coldwell maintains Medpace Holdings (NASDAQ:MEDP) with a Neutral and raises the price target from $547 to $624.
3 months ago benzinga.com
Medpace Soars After Q2 Beat, Strong Backlog Fuels Higher 2026 Outlook
Medpace says second-quarter earnings and revenue beat estimates, backed by stronger bookings, backlog growth and higher 2026 guidance.
3 months ago benzinga.com
Brent Tops $100, Alphabet, Tesla Sink Nasdaq 100: Stock Market Today
Stocks slide Thursday as Brent crude breaks $100 and the 10-year yield hits an 18-month high, while Alphabet and Tesla earnings revive AI-spending doubts.
3 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers NovoCure (NASDAQ:NVCR) shares moved upwards by 27.7% to $19.88 during Thursday's regular session. The market value of their outstanding shares is at $1.8 billion. The company's, Q2 earnings…
-
3 months ago benzinga.com
Full Transcript: Medpace Hldgs Q2 2026 Earnings Call
On Thursday, Medpace Hldgs (NASDAQ:MEDP) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga…
3 months ago benzinga.com
Lockheed Martin, Quest Diagnostics, Thermo Fisher Scientific And Other Big Stocks Moving Higher On Thursday
U.S. stocks were down as Dow Jones fell 450 points on Thursday. Lockheed Martin (LMT) shares rose 11.4% on better-than-expected results. Other big gainers were NVE Corp (NVEC), Gibo Holdings Ltd…
3 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Niki BioSolutions (NASDAQ:NIKI) stock moved upwards by 44.7% to $13.01 during Thursday's pre-market session. The company's market cap stands at $73.2 million. Zhengye Biotechnology…
3 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Zhengye Biotechnology (NASDAQ:ZYBT) shares moved upwards by 24.0% to $1.71 during Wednesday's after-market session. The market value of their outstanding shares is at $135.0 million. Medpace…
-
3 months ago benzinga.com
Medpace Holdings Raises FY2026 GAAP EPS Guidance from $16.68-$17.50 to $17.25-$17.95 vs $16.97 Est; Raises FY2026 Sales Guidance from $2.755B-$2.855B to $2.805B-$2.885B vs $2.778B Est
Medpace Holdings (NASDAQ:MEDP) raises FY2026 GAAP EPS guidance from $16.68-$17.50 to $17.25-$17.95 vs $16.97 analyst estimate. Raises FY2026 sales outlook from $2.755 billion-$2.855 billion to $2.805…
-
3 months ago benzinga.com
Medpace Hldgs Q2 EPS $4.25 Beats $3.97 Estimate, Sales $707.331M Beat $687.647M Estimate
Medpace Hldgs (NASDAQ:MEDP) reported quarterly earnings of $4.25 per share which beat the analyst consensus estimate of $3.97 by 7.05 percent. This is a 37.1 percent increase over earnings of $3.10…
3 months ago benzinga.com
Earnings Scheduled For July 22, 2026
Companies Reporting Before The Bell • Northern Trust (NASDAQ:NTRS) is expected to report quarterly earnings at $3.45 per share on revenue of $2.35 billion. • Old National Bancorp (NASDAQ:ONB) is…
-
3 months ago benzinga.com
Mizuho Maintains Outperform on Medpace Holdings, Raises Price Target to $586
Mizuho analyst Ann Hynes maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $495 to $586.
3 months ago benzinga.com
This HCA Healthcare Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Top Wall Street analysts changed outlook on top names, see all changes on analyst ratings page. HCA downgraded and price target slashed.
-
3 months ago benzinga.com
Baird Downgrades Medpace Holdings to Neutral, Raises Price Target to $547
Baird analyst Eric Coldwell downgrades Medpace Holdings (NASDAQ:MEDP) from Outperform to Neutral and raises the price target from $477 to $547.
3 months ago benzinga.com
This Truist Financial Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Top Wall Street analysts changed outlook on some top names. Check all changes on analyst ratings page. See how others view TFC stock before buying.
-
3 months ago benzinga.com
Jefferies Downgrades Medpace Holdings to Hold, Raises Price Target to $515
Jefferies analyst David Windley downgrades Medpace Holdings (NASDAQ:MEDP) from Buy to Hold and raises the price target from $490 to $515.
5 months ago benzinga.com
Congressman Looking For Dividends? Taylor Ditches 2 Magnificent Seven Stocks For Blue Chips
A congressman ditches some Magnificent Seven stocks to buy some blue-chip, high dividend yield stocks.
6 months ago benzinga.com
Tractor Supply, Lululemon, and Northrop Grumman Are Among Top 10 Large-Cap Losers Last Week (April 20-April 24): Are The Others In Your Portfolio?
Large-cap stocks slid sharply last week, pressured by earnings misses, weak guidance and analyst downgrades across sectors.
-
6 months ago benzinga.com
Barclays Maintains Equal-Weight on Medpace Holdings, Lowers Price Target to $450
Barclays analyst Luke Sergott maintains Medpace Holdings (NASDAQ:MEDP) with a Equal-Weight and lowers the price target from $500 to $450.
-
6 months ago benzinga.com
BMO Capital Maintains Market Perform on Medpace Holdings, Lowers Price Target to $400
BMO Capital analyst Sean Dodge maintains Medpace Holdings (NASDAQ:MEDP) with a Market Perform and lowers the price target from $460 to $400.
-
6 months ago benzinga.com
RBC Capital Maintains Outperform on Medpace Holdings, Lowers Price Target to $484
RBC Capital analyst Ryan Halsted maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and lowers the price target from $522 to $484.
-
6 months ago benzinga.com
Baird Maintains Outperform on Medpace Holdings, Lowers Price Target to $477
Baird analyst Eric Coldwell maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and lowers the price target from $565 to $477.
6 months ago benzinga.com
Medpace Flags Rising Cancellations, Near-Term Growth Uncertain
Medpace stock drops despite Q1 beat as cancellations rise, bookings miss weighs on outlook and management flags near-term uncertainty.
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session